CD8A and neoplasm: Proof of concept studies in a single melanoma patient revealed pre-existing humoral and cytotoxic CD8+ T-cell responses to NY-ESO-1 expressed by the patient’s tumour, clearly suggesting the NY-ESO-1′s innate potential to stimulate antitumour responses [134].